|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Heart disease is the number one killer of men and women across the United States, with nearly 2,400 Americans dying from cardiovascular disease each day. With the goal of reducing that statistic, the University of Miami Health System (UHealth) has launched the HeartAware screening program. HeartAware is a national program that provides a confidential heart screening to help identify and manage risk factors. “This is a critical tool that can help identify people who are at risk,” says William O’Neill, M.D., chief medical officer of UHealth. The test can be taken online in just seven minutes. O’Neill, a renowned interventional cardiologist, stresses that this simple questionnaire is so critical that it should be taken by every man over the age of 40 and every woman over the age of 50. Smokers, diabetics and those with a family history of heart disease should take the screening at an even earlier age.
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Alonzo Mourning, Miami Heat star and kidney transplant recipient, is the new spokesman for the Miami Transplant Institute at Jackson Memorial Hospital and the University of Miami Miller School of Medicine. The announcement was made at a news conference this morning on the medical campus in Miami attended by Pascal J. Goldschmidt, M.D., dean of the Miller School, Marvin O’Quinn, CEO of Jackson Memorial Health System, Andreas Tzakis, M.D., Ph.D., director of the Miami Transplant Institute, and Mourning.
“I know firsthand that transplantation saves lives and I want to lend my voice and influence to build the Miami Transplant Institute into a world leader in clinical care and research,” said Mourning, who congratulated the institute for the 7,000 kidney transplants it has performed. “I am a huge believer in the work done by Dr. Tzakis and I share his vision for the future. Together as a team, we can have a championship in the medical world.”
|
Pascal J. Goldschmidt, M.D., senior vice president for medical affairs and dean of the University of Miami Miller School of Medicine, delivered a guest lecture at the Aula Magna of University of Pisa Medical School in honor of the late Renzo Romanelli, M.D. The Sept. 16 presentation was titled “Predicting Cardiovascular Illness for the 21st Century.”
Leaders from the University of Pisa were in the audience including Professor Mario Petrini, chair of hematology; Professor Paolo Barachini, chair of dermatology; Professor Antonio Salvetti, director of internal medicine; Professor Alberto Balbarini, director of cardio-thoracic surgery and many other faculty members, residents and students.
|
Thomas J. Balkany, M.D., Hotchkiss Professor and Chairman of the Department of Otolaryngology at the University of Miami Miller School of Medicine, has received a Presidential Citation from the American Academy of Otolaryngology – Head and Neck Surgery. The prestigious award was presented during the opening ceremony of the organization’s annual meeting on September 21 in Chicago.
The Presidential Citation is one of the academy’s highest honors and recognizes individuals selected by the academy’s president for their outstanding contributions and dedication to the specialty at the national level. The American Academy of Otolaryngology – Head and Neck Surgery is the world’s largest organization representing 12,000 physicians who treat the ear, nose, throat, and related structures of the head and neck.
|
Emilio and Gloria Estefan have made a $25,000 donation to the University of Miami’s fundraising effort aimed at helping storm-weary Haiti.
“Gloria has been on tour in Europe, but following the tragedy unfolding so close to South Florida,” said Emilio Estefan. The Estefans interrupted the concert tour in Spain to direct funds to the University of Miami and Project Medishare, saying, “We want the Haitian community to know that we love and support them during this time of need.”
|
Camillo Ricordi, M.D., scientific director and chief academic officer of the Diabetes Research Institute and a Distinguished Professor of Medicine at the University of Miami Miller School of Medicine, delivered the prestigious Galileo Lecture on September 8 at the 44th Annual Meeting of the European Association for the Study of Diabetes in Rome. The presentation was made at the opening plenary session of the Congress before 15,000 delegates from around the world. Representatives from several Italian media outlets also turned out for the lecture and provided coverage in the evening newscasts and in local newspapers.
Ricordi’s lecture was titled Islet Transplantation Beyond Systemic Immunosuppression: Cellular Therapies Meet Bioengineering. During his lecture, Ricordi looked at the progress made in islet cell transplantation as a possible cure for type 1 diabetes. He specifically traced the progress of the Edmonton protocol for immunosuppression over the past decade, while talking about new strategies under evaluation to further improve long-term clinical outcomes.
|
University of Miami Miller School of Medicine is a leader in the South Florida effort to bring relief to the storm-ravaged nation of Haiti. In a few short weeks, Haiti has been the target of four storms that have caused hundreds of deaths, destroyed homes and left torrential flooding. Today, Pascal J. Goldschmidt, M.D., senior vice president for medical affairs and dean, and Bart Chernow, M.D., vice president for special programs and resource strategy, appeared at a news conference organized by Miami Mayor Manny Diaz and City Commissioner Michelle Spence-Jones to urge residents to contribute to the storm relief effort.
“The Miller School’s commitment to providing assistance and medical care to Haiti has never been stronger than it is during this terrible time of need,” said Dean Goldschmidt. For many years UM’s Project Medishare, co-founded by Barth Green, M.D., professor and chairman of neurological surgery, and Arthur Fournier, M.D., professor of family medicine and associate dean for community health, has been providing medical care to one of Haiti’s poorest regions, the Central Plateau. Now the Miller School’s outreach is increasing to meet the dire need created by these storms. Over the past week Project Medishare has been featured in a number of relief stories and Dr. Fournier has been interviewed by The Miami Herald, The Sun-Sentinel and NBC6, detailing the effort to get help to Haiti.
|
Researchers at the University of Miami Miller School of Medicine, led by Nanette Bishopric, M.D., have made a discovery that identifies a key molecule responsible for excessive growth of the heart muscle, or hypertrophy, which may lead to heart failure. The findings could lead to new preventive therapies for adults and children.
The molecule, acetyltransferase p300, is essential for cardiac development. Using mouse models, the research team found that excess amounts of p300 in the heart lead to a corresponding degree of hypertrophy. Reducing p300 resulted in less hypertrophy in response to stress such as high blood pressure, and too much p300 led to spontaneous hypertrophy and eventually to heart failure and death.
A new study published in the Archives of Internal Medicine by University of Miami and University of Maryland researchers shows the importance of physical activity in preventing weight gain even in people with a genetic predisposition to obesity.
For the third year in a row, the University of Miami Leonard M. Miller School of Medicine has been named one of the best medical schools in the country for Hispanic students, according to the September 2008 issue of Hispanic Business magazine.
New findings from the largest secondary stroke prevention study ever conducted will help physicians determine the medications most likely to prevent second strokes in their patients.
|
Copyright © 1997-2007 University of Miami, All Rights Reserved. |
Terms of Use Privacy Statement Contact Us |
Medical Disclaimer Site Map Web Technology |